RXRX financials
Recursion (RXRX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
RXRX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $74.68M | -$46.27M | -$648.13M | -$644.76M | -1.44 |
| 2024 | $58.84M | $13.60M | -$479.00M | -$463.66M | -1.69 |
| 2023 | $43.88M | $1.29M | -$350.06M | -$328.07M | -1.58 |
| 2022 | $39.68M | -$8.59M | -$245.73M | -$239.48M | -1.36 |
| 2021 | $10.00M | $10.00M | -$182.78M | -$186.48M | -1.05 |
| 2020 | $3.41M | $3.41M | -$84.61M | -$87.01M | -0.52 |
- RXRX revenue was $74.68M in fiscal 2025, net income -$644.76M.
Updated 2026-11-07 11:56 UTC